Viveon Health Acquisition Overview
Viveon Health Acquisition (VHAQ) has a ROE of 9.24%, above the sector sector average of -5.87%.
Get informed when a big investor buys or sells
+ Follow9.24%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for VHAQ is 9.24%. That is above the sector sector average of -5.87%. Investors often review this figure alongside Viveon Health Acquisition's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, VHAQ currently prints 9.24% for ROE, while the sector average sits near -5.87%. That is roughly 257.4% above the sector mean. Large gaps often invite a closer look at Viveon Health Acquisition's growth, margins, and balance sheet.
Return on Equity shows how effectively Viveon Health Acquisition converts resources into returns. At 9.24%, VHAQ may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting VHAQ's ROE (9.24%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
